ARTICLE | Company News
BioRelix, Dalton Chemical Laboratories Inc. deal
April 6, 2009 7:00 AM UTC
The partners expanded and renewed a 2007 deal under which Dalton is designing and synthesizing compounds against riboswitch targets from BioRelix. Terms were not disclosed. BioRelix is developing anti...